Knight Therapeutics Investor Relations Material
Latest events
M&A Announcement
Knight Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Knight Therapeutics Inc
Access all reports
Knight Therapeutics Inc is a Canadian specialty pharmaceutical company that acquires, licenses, and commercializes prescription medicines for the Canadian and Latin American markets. The company focuses on late-stage or commercial products across therapeutic areas such as oncology, infectious diseases, and ophthalmology. Knight Therapeutics Inc is headquartered in Montreal, Canada, and its shares are listed on the TSX.
Latest articles
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
Ticker symbol
GUD
Country
🇨🇦 Canada